|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
31 August 2015 |
|
Main ID: |
NCT02527577 |
|
Date of registration:
|
14/08/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection.
BLOC-TAP |
|
Scientific title:
|
Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection |
|
Date of first enrolment:
|
April 2010 |
|
Target sample size:
|
39 |
|
Recruitment status: |
Terminated |
|
URL:
|
https://clinicaltrials.gov/show/NCT02527577 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
carine.labruyere@chu-st-etienne.fr MOLLIEX, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
CHU de SAINT-ETIENNE |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- hepatectomy or segmentectomy
Exclusion Criteria:
- Sepsis uncontrolled current
- Overdose in anticoagulant during general anesthesia
- Thrombocytopenia <50 g / dl
- Severe renal impairment: Cockcroft <30 ml / min
- history of ventricular arrhythmia serious unexplained .*
- Allergy to local anesthetics of the amide
- Contraindication to remifentanil and morphine
- Hypovolemia
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Liver Cancer, Adult
|
|
Intervention(s)
|
|
Drug: Placebo
|
|
Drug: RopivacaIne chlorhydrate
|
|
Primary Outcome(s)
|
|
consumption of morphine over the first 48 hours postoperative.
[Time Frame: at 48 hours postoperative]
|
|
Secondary Outcome(s)
|
|
pharmacokinetic of ropivacaine (plasma concentrations)
[Time Frame: 1, 2, 3, 6, 10, 24, 36, 48 hours post-dose]
|
|
Secondary ID(s)
|
|
0908127
|
|
2009-017768-18
|
|
A100140-28
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|